BDTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Black Diamond Therapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$1.81+0.09 (+5.23%)
Close on Oct 19, 2026
- Market cap
- $103.83M
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Black Diamond Therapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 5, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 5, 2026 | Aug 5, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 26, 2026 | Jun 29, 2026 | SEC EDGAR |
| Current report | 8-K | May 21, 2026 | May 21, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 7, 2026 | SEC EDGAR |
| Current report | 8-K | May 7, 2026 | May 7, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 26, 2026 | Apr 29, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 16, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 16, 2026 | Mar 16, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 3, 2025 | Dec 3, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 6, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 6, 2025 | Nov 6, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 7, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 7, 2025 | Aug 7, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 12, 2025 | Jun 12, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 12, 2025 | SEC EDGAR |
| Current report | 8-K | May 12, 2025 | May 12, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 12, 2025 | Apr 18, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 18, 2025 | Mar 19, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Mar 6, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 6, 2025 | Mar 6, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 5, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 5, 2024 | Nov 5, 2024 | SEC EDGAR |
| Current report | 8-K | Oct 7, 2024 | Oct 7, 2024 | SEC EDGAR |
| Current report | 8-K | Sep 23, 2024 | Sep 23, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 6, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 6, 2024 | Aug 6, 2024 | SEC EDGAR |
| Current report | 8-K | Jun 6, 2024 | Jun 6, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2024 | May 9, 2024 | SEC EDGAR |
| Current report | 8-K | May 9, 2024 | May 9, 2024 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 6, 2024 | Apr 24, 2024 | SEC EDGAR |
| Current report | 8-K | Apr 10, 2024 | Apr 11, 2024 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2023 | Mar 12, 2024 | SEC EDGAR |
| Current report | 8-K | Mar 12, 2024 | Mar 12, 2024 | SEC EDGAR |
| Current report | 8-K | Jan 17, 2024 | Jan 18, 2024 | SEC EDGAR |
| Current report | 8-K | Jan 4, 2024 | Jan 4, 2024 | SEC EDGAR |
| Current report | 8-K | Dec 13, 2023 | Dec 13, 2023 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2023 | Nov 6, 2023 | SEC EDGAR |
| Current report | 8-K | Nov 6, 2023 | Nov 6, 2023 | SEC EDGAR |
| Current report | 8-K | Sep 15, 2023 | Sep 18, 2023 | SEC EDGAR |